Donal O'Connor, Director at Theravance Biopharma, Inc. (TBPH), sold 6,673 shares at $20.19 ($136K) on 2019-05-17, disclosed to the SEC on 2019-05-20.
Seasonal sale ($136k) by Director — this insider has traded TBPH in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.00 | 1,327 | $28K | 20.5% |
| 2 | $20.19 | 2,673 | $54K | 39.7% |
| 3 | $20.19 | 2,673 | $54K | 39.7% |
| Total | $20.35 avg | 6,673 | $136K | 100% |